載入...
A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis
BACKGROUND: Teriflunomide is a once-daily oral immunomodulator for the treatment of relapsing−remitting MS. OBJECTIVE: To evaluate the safety and tolerability of teriflunomide as add-on therapy to a stable dose of glatiramer acetate (GA) in patients with relapsing forms of MS (RMS). METHODS: Phase I...
Na minha lista:
| 發表在: | Mult Scler J Exp Transl Clin |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5433345/ https://ncbi.nlm.nih.gov/pubmed/28607708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217315618687 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|